Sign Up Today and Learn More About KSQ Therapeutics Stock
Invest in or calculate the value of your shares in KSQ Therapeutics or other pre-IPO companies through EquityZen's platform.
About KSQ Therapeutics Stock
Founded
2015
Headquarters
Cambridge, MA, US
Total Funding
156M
Industries
Science and Engineering, Health Care, Biotechnology
KSQ Therapeutics states that it is pioneering High-Confidence Drug Development: a fundamentally new approach to R&D where the majority of the de-risking work is done prior to the generation of therapeutic drug candidates. Powered by a proprietary CRISPRomics™ drug discovery engine, their team has elucidated the function that each human gene plays in multiple diseases, providing a more comprehensive understanding of disease biology. The quality of these insights enables their scientists to identify and validate high-confidence, patient-tailored drug targets and then focus their collective efforts on the development of medicines with the greatest potential to impact the lives of patients. KSQ has initiated a pipeline of preclinical discovery programs and was founded in 2015.
KSQ Therapeutics Press Mentions
Stay in the know about the latest news on KSQ Therapeutics
Guide RNA combinations and methods of use
patents • May 04, 2025
Methods for measuring and improving CRISPR reagent function
patents • Apr 03, 2025
Methods for screening for cancer targets
patents • Apr 03, 2025
Gene-regulating compositions and methods for improved immunotherapy
patents • Feb 14, 2025
Guide rna combinations and methods of use
patents • Feb 14, 2025
KSQ Therapeutics Management
Leadership team at KSQ Therapeutics
CSO
Frank Stegmeier
Founder
David Sabatini
Join now and verify your accreditation status to gain access to:
- KSQ Therapeutics Current Valuation
- KSQ Therapeutics Stock Price
- KSQ Therapeutics Management
- Available deals in KSQ Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- KSQ Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- KSQ Therapeutics Revenue and Financials
- KSQ Therapeutics Highlights
- KSQ Therapeutics Business Model
- KSQ Therapeutics Risk Factors
- KSQ Therapeutics Research Report from SACRA Research
Trading KSQ Therapeutics Stock
How to invest in KSQ Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like KSQ Therapeutics through EquityZen funds. These investments are made available by existing KSQ Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell KSQ Therapeutics stock?
Shareholders can sell their KSQ Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
